This Act reauthorizes the federal program under the Public Health Service Act that supports residential treatment for pregnant and postpartum women. It updates program language to emphasize health care services, adds an outreach planning requirement focused on women disproportionately affected by maternal substance use disorder, and increases the annual funding authorization for fiscal years 2025 through 2029.
These changes are intended to sustain access to treatment and to encourage more targeted, equity-oriented implementation.
At a Glance
What It Does
The bill amends Section 508 to replace the phrase 'providing health services' with 'providing health care services' in subsection (d)(11)(C). It also adds in subsection (g) a requirement for a plan describing outreach to women disproportionately impacted by maternal substance use disorder, and it updates the funding authorization in subsection (s) to $38,931,000 per year for FY2025–FY2029.
Who It Affects
Direct grantees and residential treatment facilities funded under the program, along with corresponding public health agencies at the federal and state level that administer these grants.
Why It Matters
These changes modernize the program’s scope, embed targeted outreach to underserved populations, and provide a longer funding horizon to sustain operations and improve outcomes for mothers and infants.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Act preserves the core purpose of the current program—supporting residential treatment for pregnant and postpartum women—while making three concrete changes. First, it substitutes the language 'health services' with 'health care services,' signaling a broader, more comprehensive set of services within the program.
Second, it adds an outreach planning requirement that explicitly invites applicants to describe how they will target women disproportionately affected by maternal substance use disorder, aligning program implementation with equity considerations. Third, it increases annual authorization levels from the prior baseline to $38,931,000 for each year from 2025 through 2029, providing more sustained funding for grantees.
Taken together, these adjustments aim to stabilize funding, clarify the program’s reach, and promote targeted outreach within residential treatment for this population.
The Five Things You Need to Know
The bill increases the annual funding authorization to $38,931,000 for FY2025–FY2029.
, , ,.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short Title
Cites the Act as the Pregnant and Postpartum Women Treatment Reauthorization Act.
Reauthorization of Program
Amends Section 508 of the Public Health Service Act to reauthorize the residential treatment program for pregnant and postpartum women. The amendments include changes to subsection (d)(11)(C), (g), and (s) to reflect updated scope, planning, and funding.
Language update: health care services
Replaces 'providing health services' with 'providing health care services' to broaden the scope of covered activities within the program, aligning it with comprehensive medical care for the target population.
Outreach planning requirement
Adds a planning requirement that the applicant will describe how outreach will be conducted and may include a description of targeting outreach to women disproportionately impacted by maternal substance use disorder.
Funding authorization increase
Raises the annual funding authorization to $38,931,000 for each of FY2025–2029, signaling a higher sustained investment in residential treatment for this population.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Pregnant and postpartum women with substance use disorders gain access to a broader set of health care services when they utilize residential treatment programs.
- Residential treatment providers receive a clearer funding framework and updated requirements that can improve program planning and delivery.
- State and federal public health agencies administering the program gain a more explicit mandate for equity-focused outreach and planning.
- Perinatal care teams and affiliated clinics coordinating with treatment programs benefit from integrated planning and clearer expectations.
Who Bears the Cost
- Federal budgeting authorities must authorize increased funding, which may affect annual appropriations.
- Grantees incur costs to develop and implement outreach plans and potentially to broaden service delivery to meet the updated scope.
- Residential treatment providers may face administrative and reporting costs to align with the new outreach planning requirements.
Key Issues
The Core Tension
Balancing expanded scope and equity-focused outreach with finite federal funding and administrative capacity—will broader service definitions and targeted outreach translate into measurable improvements in access and outcomes without overburdening grantees?
The bill’s changes emphasize equity and continuity of care but raise implementation questions that deserve attention. The shift from 'health services' to 'health care services' could broaden the program’s obligations, but it depends on how the funding streams and waivers are administered at the agency level.
The outreach planning requirement is a positive signal for targeted access; however, success will hinge on clear metrics, data availability, and the capacity of grantees to identify and reach women disproportionately affected by maternal substance use disorder. Finally, the funding increase improves program stability but remains contingent on appropriations, so actual disbursements will depend on the annual budget process and potential administrative overhead.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.